Improvements in health care and lifestyle have led to an elevated lifespan and increased
focus on age-associated diseases, such as neurodegeneration, cardiovascular disease …

Advanced glycation end-products (AGEs) are a heterogeneous group of compounds formed
by the Maillard chemical process of non-enzymatic glycation of free amino groups of …

Background. Aging is a complex multifactorial process characterized by accumulation of
deleterious changes in cells and tissues, progressive deterioration of structural integrity and …

Advanced glycation end-product (AGE) is the generic term for a heterogeneous group of
derivatives arising from a non-enzymatic reaction between reducing sugars and proteins. In …

Advanced glycation end-products (AGEs) have been implicated in chronic hyperglycemia
and age-related diseases. Endogenous AGEs produced by humans generate oxidative …

Non-enzymatic modification of proteins by reducing sugars, a process that is also known as
Maillard reaction, leads to the formation of advanced glycation end products (AGEs) in vivo …

A nonenzymatic reaction between reducing sugars and amino groups of proteins, lipids and
nucleic acids contributes to the aging of macromolecules and subsequently alters their …

The products of nonenzymatic glycation and oxidation of proteins and lipids, the advanced
glycation end products (AGEs), accumulate in a wide variety of environments. AGEs may be …

Age-related, non-communicable chronic inflammatory diseases represent the major 21st
century health problem. Especially in Western countries, the prevalence of non …

Advanced glycation end products (AGEs) and their receptor have been implicated in the
progressions of many intractable diseases, such as diabetes and atherosclerosis, and are …